More tools:Markets·Screener·Research·Chat

Lifecore Biomedical, Inc. Common Stock (LFCR) Financial Statements

Lifecore Biomedical, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S7VTL0
XNAS · usd
4.31▼ 0.09 (-2.05%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close4.40
Day's Range4.28 – 4.40
52-Week Range3.63 – 9.00
Volume185.4K
Avg Volume137.5K
Share Statistics
Shares Outstanding
Employees382
ExchangeXNAS
Listed1996-02-15
Share count as of July 29, 2026
Loading Income Statement…
Key questions about Lifecore Biomedical, Inc. Common Stock (LFCR)
What is Lifecore Biomedical, Inc. Common Stock's Market Cap?
Lifecore Biomedical, Inc. Common Stock's Market Cap is $163.1M, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's Enterprise Value?
Lifecore Biomedical, Inc. Common Stock's Enterprise Value is $337.4M, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's Price / Sales?
Lifecore Biomedical, Inc. Common Stock's Price / Sales is 1.3×, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's EV / Revenue?
Lifecore Biomedical, Inc. Common Stock's EV / Revenue is 2.6×, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's EV / EBITDA?
Lifecore Biomedical, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's Revenue (TTM)?
Lifecore Biomedical, Inc. Common Stock's Revenue (TTM) is $128.9M, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's Net Income (TTM)?
Lifecore Biomedical, Inc. Common Stock's Net Income (TTM) is -$42.0M, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's EBITDA?
Lifecore Biomedical, Inc. Common Stock's EBITDA is -$9.2M, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's Diluted EPS (TTM)?
Lifecore Biomedical, Inc. Common Stock's Diluted EPS (TTM) is -1.11, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's EBITDA Margin?
Lifecore Biomedical, Inc. Common Stock's EBITDA Margin is -7.2%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Sep 30, 2025May 25, 2025Feb 23, 2025Nov 24, 2024Aug 25, 2024May 26, 2024Feb 25, 2024Nov 26, 2023Aug 27, 2023May 28, 2023Feb 26, 2023Nov 27, 2022Aug 28, 2022
Revenues
YoY growth+4.9%+25.9%
Cost of sales
Gross profit
% of revenue35.3%25.0%
Research and development expenses
Selling, general, and administrative expenses
Restructuring recovery—
Loss on sale or disposal of assets, net of portion classified as cost of sales—
Operating income (loss)
% of revenue7.5%-9.9%
Interest income
Interest expense——
Change in fair value of debt derivative liability, related party
Other income, net
Loss before income taxes
Income tax expense
Net loss
% of revenue-18.0%-32.1%
Preferred stock dividends
Loss available to common stockholders
Basic (in dollars per share)
Diluted (in dollars per share)